OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
Dimitrios Giannis, Demetrios Moris, Andrew S. Barbas
Cancers (2021) Vol. 13, Iss. 5, pp. 1071-1071
Open Access | Times Cited: 26
Dimitrios Giannis, Demetrios Moris, Andrew S. Barbas
Cancers (2021) Vol. 13, Iss. 5, pp. 1071-1071
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Di Jin, Najeeb Ullah Khan, Wei Gu, et al.
Neoplasia (2025) Vol. 60, pp. 101129-101129
Closed Access | Times Cited: 3
Di Jin, Najeeb Ullah Khan, Wei Gu, et al.
Neoplasia (2025) Vol. 60, pp. 101129-101129
Closed Access | Times Cited: 3
Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3.
Oscar Fraile‐Martínez, Cielo García‐Montero, Leonel Pekarek, et al.
PubMed (2024) Vol. 39, Iss. 1, pp. 35-40
Closed Access | Times Cited: 11
Oscar Fraile‐Martínez, Cielo García‐Montero, Leonel Pekarek, et al.
PubMed (2024) Vol. 39, Iss. 1, pp. 35-40
Closed Access | Times Cited: 11
An effective way to detect urinary biomarkers for pancreatic cancer using random forest algorithm with enhanced accuracy compared to XGBoost algorithm
Kakelli Anil Kumar, A. Gayathri
AIP conference proceedings (2025) Vol. 3252, pp. 020029-020029
Closed Access | Times Cited: 1
Kakelli Anil Kumar, A. Gayathri
AIP conference proceedings (2025) Vol. 3252, pp. 020029-020029
Closed Access | Times Cited: 1
HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis
Yang Yao, Chao Liu, Bojun Wang, et al.
Cancer Letters (2022) Vol. 533, pp. 215595-215595
Open Access | Times Cited: 34
Yang Yao, Chao Liu, Bojun Wang, et al.
Cancer Letters (2022) Vol. 533, pp. 215595-215595
Open Access | Times Cited: 34
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
Eramah Ermiah, Mona Mohamed Eddfair, Othman Abdulrahman, et al.
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 2
Open Access | Times Cited: 23
Eramah Ermiah, Mona Mohamed Eddfair, Othman Abdulrahman, et al.
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 2
Open Access | Times Cited: 23
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research
Ornella Cominetti, Loı̈c Dayon
Expert Review of Proteomics (2025)
Closed Access
Ornella Cominetti, Loı̈c Dayon
Expert Review of Proteomics (2025)
Closed Access
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
Natalia E. Cortez, Gerardo G. Mackenzie
Nutrients (2021) Vol. 13, Iss. 9, pp. 3202-3202
Open Access | Times Cited: 27
Natalia E. Cortez, Gerardo G. Mackenzie
Nutrients (2021) Vol. 13, Iss. 9, pp. 3202-3202
Open Access | Times Cited: 27
Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses
Cielo García‐Montero, Oscar Fraile‐Martínez, David Cobo-Prieto, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 947-947
Open Access | Times Cited: 2
Cielo García‐Montero, Oscar Fraile‐Martínez, David Cobo-Prieto, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 947-947
Open Access | Times Cited: 2
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer
Simone Furini, Chiara Falciani
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Simone Furini, Chiara Falciani
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, et al.
Cureus (2023)
Open Access | Times Cited: 5
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, et al.
Cureus (2023)
Open Access | Times Cited: 5
Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer
Chae Hwa Kwon, Hyung Il Seo, Dong Uk Kim, et al.
Korean Journal of Clinical Oncology (2023) Vol. 19, Iss. 1, pp. 11-17
Open Access | Times Cited: 4
Chae Hwa Kwon, Hyung Il Seo, Dong Uk Kim, et al.
Korean Journal of Clinical Oncology (2023) Vol. 19, Iss. 1, pp. 11-17
Open Access | Times Cited: 4
LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p
Zhaozhi Xia, Shuchao Zhao, Xin Gao, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 3
Zhaozhi Xia, Shuchao Zhao, Xin Gao, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 3
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
Sarah Maloney, Stephen Clarke, Sumit Sahni, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13437-13450
Open Access | Times Cited: 2
Sarah Maloney, Stephen Clarke, Sumit Sahni, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13437-13450
Open Access | Times Cited: 2
Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon‐Koon Yoong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2093-2093
Open Access | Times Cited: 4
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon‐Koon Yoong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2093-2093
Open Access | Times Cited: 4
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer
Sidsel C. Lindgaard, Zsófia Sztupinszki, Emil Maag, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 3972-3986
Open Access | Times Cited: 3
Sidsel C. Lindgaard, Zsófia Sztupinszki, Emil Maag, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 3972-3986
Open Access | Times Cited: 3
Molecular biomarkers in pancreatic ductal adenocarcinoma
Junya Tsuboi, Reiko Yamada, Yoshifumi Hirokawa
Elsevier eBooks (2024), pp. 151-173
Closed Access
Junya Tsuboi, Reiko Yamada, Yoshifumi Hirokawa
Elsevier eBooks (2024), pp. 151-173
Closed Access
Should liver metastases of pancreatic adenocarcinoma be resected?
Milena Muzzolini, Renato Micelli Lupinacci, Jean‐Baptiste Bachet, et al.
Journal of Visceral Surgery (2024) Vol. 161, Iss. 2, pp. 129-140
Closed Access
Milena Muzzolini, Renato Micelli Lupinacci, Jean‐Baptiste Bachet, et al.
Journal of Visceral Surgery (2024) Vol. 161, Iss. 2, pp. 129-140
Closed Access
Faut-il réséquer les métastases hépatiques d’adénocarcinome du pancréas ?
Milena Muzzolini, Renato Micelli Lupinacci, Jean‐Baptiste Bachet, et al.
Journal de Chirurgie Viscérale (2024) Vol. 161, Iss. 2, pp. 141-155
Closed Access
Milena Muzzolini, Renato Micelli Lupinacci, Jean‐Baptiste Bachet, et al.
Journal de Chirurgie Viscérale (2024) Vol. 161, Iss. 2, pp. 141-155
Closed Access
PROGNOSTIC IMPACT OF PROMOTER-HYPERMETHYLATED SFRP1 IN PANCREATIC DUCTAL ADENOCARCINOMA: A BLOOD-BASED BIOMARKER STUDY
Benjamin E. Stubbe
(2024)
Open Access
Benjamin E. Stubbe
(2024)
Open Access
Clinical characteristics, imaging diagnostic accuracy, and prognosis of autoimmune pancreatitis: A real‐world study in China
Yue Liu, Dong Wan, Zaixing Yang, et al.
Journal of Digestive Diseases (2024)
Open Access
Yue Liu, Dong Wan, Zaixing Yang, et al.
Journal of Digestive Diseases (2024)
Open Access
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 623-623
Open Access | Times Cited: 2
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 623-623
Open Access | Times Cited: 2
Computed Tomography Radiomics Signatures: Sensitive biomarkers for clinical decision support in pancreatic cancer- a pilot study
Abbas Habibalahi, Daniel Moses, Jared M. Campbell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Abbas Habibalahi, Daniel Moses, Jared M. Campbell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Clinical Assessment and Staging of Advanced Pancreatic Cancer
James Lindberg, Giles F. Whalen, Jennifer LaFemina
Pancreas (2023), pp. 1037-1046
Open Access
James Lindberg, Giles F. Whalen, Jennifer LaFemina
Pancreas (2023), pp. 1037-1046
Open Access
Prognostic Value of SMAD4 Expression in Pancreatic Ductal Adenocarcinoma and its Correlation with Clinicopathological Parameters and HER2 Status
Walaa Ahmed Yusuf, Heba Sheta, Hend Elkalla, et al.
The Egyptian Journal of Hospital Medicine (2022) Vol. 89, Iss. 1, pp. 5040-5050
Open Access
Walaa Ahmed Yusuf, Heba Sheta, Hend Elkalla, et al.
The Egyptian Journal of Hospital Medicine (2022) Vol. 89, Iss. 1, pp. 5040-5050
Open Access
